Prospective, non-comparative study of daptomycin for the treatment of superficial and deep incisional surgical site infections

Surgical Infections

Volumn 12, Issue 2, 2011, Pages 113-118

  Knapp, Andrew G ^a   Kamepalli, Ravi K ^b   Martone, William J ^a   Yankelev, Sara ^a  

^a CUBIST PHARMACEUTICALS INC   (United States)

^b Regional Infectious Diseases Infusion Center Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; DAPTOMYCIN; METRONIDAZOLE;

ABDOMINAL INJURY; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GRAM POSITIVE BACTERIUM; HUMAN; LEG THROMBOSIS; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; PHASE 4 CLINICAL TRIAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SKIN INCISION; SURGICAL INFECTION; TREATMENT RESPONSE; WOUND ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DAPTOMYCIN; FEMALE; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SKIN DISEASES, BACTERIAL; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION; TREATMENT OUTCOME; UNITED STATES;

EID: 79955762740     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2008.106     Document Type: Article

References (25)

1. Cheadle WG. Risk factors for surgical site infection. Surg Infect 2006;7(suppl 1):S7-S11.
2. Hedrick TL, Anastacio MM, Sawyer RG. Prevention of surgical site infections. Expert Rev Anti-Infect Ther 2006;4: 223-233.
3. McGarry SA, Engemann JJ, Schmader K, et al. Surgical-site infection due to Staphylococcus aureus among elderly patients: Mortality, duration of hospitalization, and cost. Infect Control Hosp Epidemiol 2004;25:461-467. (Pubitemid 38758489)
4. Inigo JJ, Bermejo B, Oronoz B, et al. Surgical site infection in general surgery: 5-Year analysis and assessment of the National Nosocomial Infection Surveillance (NNIS) index. Cir Esp 2006;79:224-230.
5. Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003;36:592-598. (Pubitemid 36259564)
6. Polk HC Jr, Simpson CJ, Simmons BP, Alexander JW. Guidelines for prevention of surgical wound infection. Arch Surg 1983;118:1213-1217. (Pubitemid 13005838)
7. Melzer M, Eykyn SJ, Gransden WR, Chinn S. Is methicillinresistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis 2003;37:1453-1460. (Pubitemid 37494672)
8. Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: National initiatives to improve outcomes for patients having surgery. Clin Infect Dis 2006;43:322-330. (Pubitemid 44088320)
9. Nichols RL. Optimal treatment of complicated skin and skin structure infections. J Antimicrob Chemother 1999;44(suppl A):19-23. (Pubitemid 29425488)
10. Doern GV, Jones RN, Pfaller MA, et al. Bacterial pathogens isolated from patients with skin and soft tissue infections: Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America). Diagn Microbiol Infect Dis 1999;34:65-72. (Pubitemid 29216939)
11. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470-485.
12. Anderson DJ, Sexton DJ, Kanafani ZA, et al. Severe surgical site infection in community hospitals: Epidemiology, key procedures, and the changing prevalence of methicillinresistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2007;28:1047-1053. (Pubitemid 47345264)
13. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298:1763-1771. (Pubitemid 47598444)
14. Cubicin (daptomycin for injection) [package insert]. Lexington, MA. Cubist Pharmaceuticals. 2006.
15. Silverman JA, Perlmutter NG, Shapiro HM. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother 2003;47:2538-2544. (Pubitemid 36919456)
16. Arbeit RD, Maki D, Tally FP, et al. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 2004;38:1673-1681. (Pubitemid 38781657)
17. Horan TC, Gaynes RP, Martone WJ, et al. CDC definitions of nosocomial surgical site infections, 1992: A modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606-608
18. Owens RC Jr, Lamp KC, Friedrich LV, Russo R. Postmarketing clinical experience in patients with skin and skinstructure infections treated with daptomycin. Am J Med 2007;120:S6-S12. (Pubitemid 47464122)
19. Gaynes RP, Culver DH, Horan TC, et al. Surgical site infection (SSI) rates in the United States, 1992-1998: The National Nosocomial Infections Surveillance System Basic SSI Risk Index. Clin Infect Dis 2001;33(suppl 2):S69-S77. (Pubitemid 32762924)
20. Moro ML, Morsillo F, Tangenti M, et al. Rates of surgical-site infection: An international comparison. Infect Control Hosp Epidemiol 2005;26:442-448. (Pubitemid 40695276)
21. Manian FA, Meyer PL, Setzer J, Senkel D. Surgical site infections associated with methicillin-resistant Staphylococcus aureus: Do postoperative factors play a role? Clin Infect Dis 2003;36:863-868. (Pubitemid 36403519)
22. Li Z, Willke RJ, Pinto LA, et al. Comparison of length of hospital stay for patients with known or suspected methicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin: A randomized, multicenter trial. Pharmacotherapy 2001;21:263-274. (Pubitemid 32208840)
23. Stevens DL, Herr D, Lampiris H, et al. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2002;34:1481-1490. (Pubitemid 34553708)
24. Li JZ, Willke RJ, Rittenhouse BE, Rybak MJ. Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: Results from a randomized clinical trial. Surg Infect 2003;4:57-70. (Pubitemid 36546749)
25. Lamp KC, Martone WJ. Daptomycin outcomes following vancomycin treatment of surgical site infections. Presented at the 28th Annual Meeting of the Surgical Infection Society, Hilton Head Island, SC, May 7-9, 2008.